AUG 13, 2026 · PHASE 2 TRIAL
A Trial of the Fatty Acid Amide Hydrolase Inhibitor Palmitoylethanolamide in Bipolar Depression
ClinicalTrials.gov
Phase 2 trial in bipolar depression with small sample (n=34) and surrogate endpoint (HAM-D); recruitment completed but no results posted in registry, limiting evidence strength.
Reported
Sample size34
PhasePhase 2
Primary endpointChange in Depression as Assessed by the Ham…